TABLE 4.

Running clinical trial studies for validation of Remdesivir (https://clinicaltrials.gov/ct2/results).

Sl. No.	Title	NCT No.	Therapeutic Dose	Phase	Location
1	Clinical trial of COVID-19	NCT04280705	Loading dose: 200 mg (Day 1), Day 2–10: 100 mg (BID)	3	U.S.
2	Estimating the efficacy of various Anti-virals for SARS-CoV-2 infection	NCT04321616	Loading dose: 100 mg (Day 1–10)	2,3	Norway
3	Trial of treatments against SARS-CoV-2 infection in Adult hospitalized patients	NCT04315948	Loading dose: 100 mg (Day1) i.v. loading dose on the first day, 100 mg once daily	3	France
4	Determination of safety and efficacy of remdesivir against severe infection of SARS-CoV-2	NCT04292899	Loading dose: 200 mg (Day1), Day 2–5: 100 mg	3	U.S.
5	Clinical trial for Determination of the safety and Activity of remdesivir in patients	NCT04292730	loading dose: 200 mg on the first day followed by 100 mg on Day 2–5	3	U.S.